Bill Mixon’s journey from portfolio company CEO to private equity executive partner provides unique insight into the evolving relationship between healthcare operators and investment firms. His experience leading Advanced Diabetes Supply Group under Court Square Capital Partners’ ownership, followed by the company’s $1.1 billion sale to Cardinal Health, positioned him for his next chapter with Reeve Waud’s Chicago-based firm.
This transition illustrates how successful healthcare executives increasingly view private equity partnerships as opportunities to scale their operational expertise across multiple platforms rather than limiting themselves to single company leadership roles.
The Portfolio Company Perspective
Mixon’s experience executing growth strategy under private equity ownership at Advanced Diabetes Supply Group provided valuable perspective on value creation methodologies. Court Square Capital Partners supported the company’s expansion from its founding base into a national platform serving approximately 500,000 patients annually.
Under Court Square’s ownership, ADSG executed operational improvements that included salesforce productivity enhancements, go-to-market strategy shifts, and margin optimization through revenue cycle initiatives. The company’s growth trajectory culminated in Cardinal Health’s strategic acquisition, validating the investment thesis and execution approach.
Jeff Abramoff, Partner at Court Square, commented on the successful partnership: “We are proud to have partnered with ADSG, its Founders, and Bill Mixon and the rest of the management team, to help the Company exceed its growth goals and enable better patient care for those with diabetes.”
Operational expertise Mixon gained managing complex patient relationships across multiple chronic disease management programs demonstrated his ability to scale healthcare services while maintaining quality outcomes. This experience became attractive to private equity firms seeking proven executives for platform-building initiatives.
The Executive Partner Model
Waud Capital Partners’ approach to executive partnerships differentiates the firm from traditional private equity models. Rather than acquiring companies and then optimizing management teams, Reeve Waud’s firm identifies exceptional executives first and then partners with them to identify and build acquisition platforms.
Reeve Waud has consistently emphasized that “exceptional people drive exceptional value,” a philosophy that drives the firm’s executive-first investment approach (https://www.waudcapital.com/en/media/waud-capital-partners-announces-three-partner-promotions-and-one-principal-promotion/). This methodology reduces execution risk by ensuring proven leadership from the initial platform investment.
The contrast with traditional private equity becomes apparent in the partnership structure. Instead of joining as hired management post-acquisition, executives like Mixon become partners in the value creation process from the beginning, aligning incentives for long-term platform building rather than short-term optimization.
Kyle Lattner, recently promoted to Partner at Waud Capital Partners, described the approach as an “executive-first campaign approach and commitment to support accomplished executive leaders with the full ecosystem of resources to execute transformative growth strategies in large, growing markets.”
Healthcare Supply Chain Focus
Healthcare supply chain sector fragmentation creates significant consolidation opportunities for experienced operators with access to investment capital. Market dynamics favor companies that can provide both product distribution and value-added services, particularly in chronic care and population health management segments.
Waud Capital’s existing healthcare supply chain investments demonstrate Reeve Waud’s sector expertise. The portfolio includes Mopec Group (pathology equipment and services), PromptCare (home infusion and durable medical equipment), and Provider Network Holdings (specialty medication supply management), providing insights across multiple healthcare delivery models.
The firm’s recent acquisition of Mopec Group from Blackford Capital resulted from a similar executive partnership with Brad Staley, who brought more than 25 years of medical supply and device services experience. This precedent demonstrates Waud Capital’s ability to execute the executive partnership model successfully.
Target areas for the Mixon partnership include home distribution services, value-add specialty distribution, outsourced provider equipment services, and chronic care and population health management solutions. These subsectors align with Mixon’s operational expertise while addressing significant market opportunities.
Mixon expressed confidence in the partnership structure: “I believe this combination will enable us to capitalize on transformative growth opportunities, and I look forward to leveraging my past experiences to drive clinical value for medical professionals, manufacturers, payors and most importantly, patients.”
Reeve Waud’s evolution from founding a single-person operation in 1993 to managing $4.6 billion in assets demonstrates the long-term potential of executive partnerships in healthcare investing. The firm’s track record of more than 500 completed investments provides the foundation for ambitious platform-building initiatives like the Mixon collaboration, positioning both parties to capitalize on continued healthcare supply chain consolidation opportunities.
